Lobbying client

COLOSSAL BIOSCIENCES INC.

Biotechnology

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
17
Filed by
3
Reported in-house
—
Reported by firms
$716,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2024 to 2026

Filings

17 filings, newest first.
Filing Filed by Amount
3rd Quarter - Report
3rd Quarter 2026
MILLER STRATEGIES, LLC $90,000 reported
3rd Quarter - Report
3rd Quarter 2026
CAPITOL CONNECTIONS, LLC $24,000 reported
2nd Quarter - Termination
2nd Quarter 2026
ATLAS CROSSING LLC $60,000 reported
2nd Quarter - Report
2nd Quarter 2026
MILLER STRATEGIES, LLC $50,000 reported
2nd Quarter - Report
2nd Quarter 2026
CAPITOL CONNECTIONS, LLC $24,000 reported
Registration
2nd Quarter 2026
MILLER STRATEGIES, LLC — reported
1st Quarter - Report
1st Quarter 2026
CAPITOL CONNECTIONS, LLC $24,000 reported
1st Quarter - Report
1st Quarter 2026
ATLAS CROSSING LLC $60,000 reported
4th Quarter - Report
4th Quarter 2025
ATLAS CROSSING LLC $60,000 reported
4th Quarter - Report
4th Quarter 2025
CAPITOL CONNECTIONS, LLC $24,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
ATLAS CROSSING LLC 8 $480,000
MILLER STRATEGIES, LLC 2 $140,000
CAPITOL CONNECTIONS, LLC 4 $96,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Animals ANI 17
Science/Technology SCI 12
Copyright/Patent/Trademark CPT 3
Budget/Appropriations BUD 2

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.